Leonteq Securities’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.42K Buy
2,888
+1,479
+105% +$4.33K ﹤0.01% 1046
2026
Q2
$4.56K Hold
1,409
– – ﹤0.01% 1098
2026
Q1
$3.48K Hold
1,409
– – ﹤0.01% 1139
2025
Q4
$2.89K Hold
1,409
– – ﹤0.01% 1295
2025
Q3
$4.89K Buy
1,409
+651
+86% +$1.82K ﹤0.01% 1172
2025
Q2
$1.67K Hold
758
– – ﹤0.01% 1185
2025
Q1
$879 Hold
758
– – ﹤0.01% 1172
2024
Q4
$963 Hold
758
– – ﹤0.01% 1189
2024
Q3
$2.58K Buy
758
+593
+359% +$2.58K ﹤0.01% 1085
2024
Q2
$771 Buy
+165
New +$931 ﹤0.01% 1141
2021
Q4
– Sell
-43
Closed -$1.77K – 1286
2021
Q3
$1.77K Buy
+43
New +$2.36K ﹤0.01% 1098

Other funds holding EDIT

Leonteq Securities's EDIT Position: Q3 2026 in Review

Leonteq Securities increased its Editas Medicine (EDIT) stake by 105% in Q3 2026, buying an estimated $4.33K and bringing the position to 2,888 shares worth $7.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1046.

Leonteq Securities first reported a position in EDIT in Q3 2021 and has held it in 11 quarters since. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • Leonteq Securities held 2,888 shares of Editas Medicine worth $7.42K as of Q3 2026.
  • Leonteq Securities bought 1,479 Editas Medicine shares in Q3 2026, an estimated $4.33K.
  • Editas Medicine made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1046 holding.
  • Leonteq Securities first reported a position in Editas Medicine in Q3 2021 and has held it in 11 quarters since.
  • 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.